Your browser doesn't support javascript.
loading
Review of Survival, Safety, and Clinical Outcomes in HER2+ Metastatic Gastric Cancer Following the Administration of Trastuzumab.
Hackshaw, Michelle D; Bui, Christine L; Ladner, Amy; Tu, Nora; Islam, Zahidul; Ritchey, Mary E; Salas, Maribel.
Afiliación
  • Hackshaw MD; Department of Medical Affairs for Global Medical Affairs, Daiichi Sankyo, Basking Ridge, NJ, USA.
  • Bui CL; Department of Epidemiology, RTI Health Solutions, Research Triangle Park, NC, USA.
  • Ladner A; Department of Epidemiology, RTI Health Solutions, Research Triangle Park, NC, USA.
  • Tu N; Department of Epidemiology, Clinical Safety and Pharmacovigilance, Daiichi Sankyo, Basking Ridge, NJ, USA.
  • Islam Z; Department of Epidemiology, Clinical Safety and Pharmacovigilance, Daiichi Sankyo, Basking Ridge, NJ, USA.
  • Ritchey ME; Department of Epidemiology, RTI Health Solutions, Research Triangle Park, NC, USA.
  • Salas M; Department of Epidemiology, Clinical Safety and Pharmacovigilance, Daiichi Sankyo, Basking Ridge, NJ, USA; CCEB/CPeRT, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA. Electronic address: msalas@dsi.com.
Cancer Treat Res Commun ; 24: 100189, 2020.
Article en En | MEDLINE | ID: mdl-32673845

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Trastuzumab Tipo de estudio: Prognostic_studies / Systematic_reviews Idioma: En Revista: Cancer Treat Res Commun Año: 2020 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Trastuzumab Tipo de estudio: Prognostic_studies / Systematic_reviews Idioma: En Revista: Cancer Treat Res Commun Año: 2020 Tipo del documento: Article